Why the study?
The late consequences of ACS have been underestimated, prompting investigation into how the temporal distribution of clinically silent coronary artery disease progression relates to subsequent consequences.
Does clinically silent coronary artery disease progression in the early or late phases after acute coronary syndrome predict subsequent major adverse cardiovascular and cerebrovascular events?
Does clinically silent coronary artery disease progression in the early or late phases after acute coronary syndrome predict subsequent major adverse cardiovascular and cerebrovascular events?
Clinically silent coronary artery disease progression in both the early and late phases after an acute coronary syndrome is independently associated with a higher risk of subsequent major adverse cardiovascular and cerebrovascular events.
Answers are grounded in this paper and cite their sources.
Silent CAD progression may flag higher-risk post-ACS patients; leaves open whether monitoring or intervention alters MACCEs.
The late consequences of acute coronary syndrome (ACS) have been underestimated. We hypothesized that the temporal distribution of the clinically silent coronary artery disease progression (CP) is associated with the subsequent consequences of ACS.We studied 243 patients (202 men, 64 ± 10 years) with ACS undergoing percutaneous coronary intervention (PCI) during initial hospitalization. All patients underwent serial coronary angiograms (CAGs) immediately before PCI and at 7 ± 3 and 60 ± 10 months after presentation. CP was defined as an increase ≥ 15% in stenosis severity of the lesion between 2 serial CAGs. The impact of CP between each 2 serial CAGs on subsequent major adverse cardiovascular and cerebrovascular events (MACCEs) after the final CAG was examined using multivariate Cox and propensity-matched analyses.During the median follow-up duration after the final CAG of 67 months, 76 MACCEs (31.3%) were observed. Multivariate Cox proportional hazards analysis revealed that CP between the first and second CAGs (hazard ratio [HR], 2.28; 95% confidence interval [CI], 1.32-3.94; P = 0.003) and CP between the second and final CAGs (HR, 1.96; 95% CI, 1.20-3.21; P = 0.008) were independently associated with a higher rate of MACCEs beyond the final CAG. Consistent results were obtained in the propensity score-matched analyses.CP in both the early (0-7 months) and late phases (7-60 months) were independently associated with subsequent clinical events. This may indicate the prognostic significance of persistent widespread coronary disease activity following presentation in patients with ACS undergoing PCI.
No takes yet. Share an insight, caveat, or question.
Nakachi et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: